Hoverink biotechnologies inc

Author: dequ

August undefined, 2024

WebDebbie Mae Carter is Former CEO/Treasurer at Hoverink Biotechnologies Inc. See Debbie Mae Carter's compensation, career history, education, & memberships. Web9 de nov. de 2024 · Hoverink Biotechnologies, Inc plans to develop and commercialize KAIYADRU® Hoverink Biotechnologies, Inc., today announced that they have completed an application with the USPTO for KAIYADRU®. [November 09, 2024]

Hoverink Biotechnologies, Inc., today announced that they have ...

Web20 de dez. de 2024 · Pre-Clinical Trials. 1. Angel (individual) 05-Mar-2024. $2.5M. Cancelled. Pre-Clinical Trials. To view Hoverink Biotechnologies’s complete valuation … Web21 de mai. de 2024 · Our mission is to improve the lives of patients who suffer from rare diseases for which there are... Los Angeles, CA 90067 shanth a thimmaiah

SEC FORM D

WebWHEREAS, the Board of Hoverink Biotechnologies, Inc., a Delaware Corporation (the “Company”), has determined that the grant of Restricted shares of the Company’s … Web9 de nov. de 2024 · Contact Data Hoverink Biotechnologies, Inc. 1801 Century Park East., 24th Floor Los Angeles, California 90067 866-443-4666 [email protected] pond dramatic play

Hoverink International Holdings, Inc - Home

Hoverink Biotechnologies, Inc., today announced that they

WebHoverink Biotechnologies, Inc is primarely in the business of pharmaceutical preparations. For financial reporting, their fiscal year ends on December 31st. This page includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Hoverink Biotechnologies, Inc.. WebHoverink Biotechnologies, Inc. Street Address 1 Street Address 2; 1801 CENTURY PARK EAST: 24TH FLOOR: City State/Province/Country ZIP/PostalCode Phone Number of … pond diseaseWeb5 de jul. de 2024 · LOS ANGELES, CA, July 05, 2024 (GLOBE NEWSWIRE) -- HOVERINK BIOTECHNOLOGIES, seeks to enter into a licensing agreement for the exclusive rights to commercialize LADAVRU(TM) (Dronabinol for injection) and an oral formulation of LADAVRU®. HOVERINK BIOTECHNOLOGIES seeks to partner and receive an up-front … shantha towers

"WebPresently, Davidra Nicole Sajna holds the position of Chairman for Hoverink Biotechnologies, Inc. Ms. Sajna received an undergraduate degree from Texas State University, an undergraduate degree from... " - Hoverink biotechnologies inc

Hoverink biotechnologies inc

Web26 de set. de 2024 · Trademark Overview. On Wednesday, September 26, 2024, a trademark application was filed for KAIYADRU with the United States Patent and Trademark Office. The USPTO has given the KAIYADRU trademark a serial number of 88133141. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE … WebHoverink Biotechnologies Inc. Hoverink Biotechnologies, Inc. operates as a preclinical biopharmaceutical company. The Company develops and manufactures drug for age …

Did you know?

Web27 de set. de 2024 · CENTURY CITY, CA / ACCESSWIRE / September 26, 2024 / Hoverink Biotechnologies, Inc., today announced that they have plans to develop and … Web12 de nov. de 2024 · Hoverink Biotechnologies, Inc plans to develop and commercialize MAXKAFLEN® a cattle and swine antibiotic. 12 nov. 2024 14h30 HE Source: Hoverink …

Web26 de set. de 2024 · CENTURY CITY, CA / ACCESSWIRE / September 26, 2024 / Hoverink Biotechnologies, Inc., today announced thatthey have plans to develop and … Web27 de mar. de 2024 · Hoverink Biotechnologies doesn't have any recent trademark applications, indicating Hoverink Biotechnologies is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans. Trademark ...

WebHoverink Biotechnologies, Inc. 1801 Century Park E., 24th Floor Los Angeles, California 90067 [email protected] 866-443-4666 (Name, address, including zip code, and … WebWHEREAS, the Board of Hoverink Biotechnologies, Inc., a Delaware Corporation (the “Company”), has determined that the grant of Restricted shares of the Company’s Common Stock to Cyrus Sajna , (the “Vice President”) in recognition and appreciation of services previously performed by the Vice President on behalf of the Company is an effective …

Web28 de abr. de 2024 · LOS ANGELES, CA, April 27, 2024 (GLOBE NEWSWIRE) -- Hoverink Biotechnologies, Inc announced today it intends to offer, subject to market and other conditions, $2.5 million of Series A Convertible Notes, through a Regulation D 506(b) offering to qualified buyers.

Web12 de nov. de 2024 · Hoverink Biotechnologies, Inc plans to develop and commercialize MAXKAFLEN® a cattle and swine antibiotic. 12 nov. 2024 14h30 HE Source: Hoverink Biotechnologies, Inc. Overview. LOS ANGELES, CA, Nov. 12, 2024 (GLOBE NEWSWIRE) -- On September 26, 2024 ... pond drive abingdon vaWebHoverink Biotechnologies, Inc Los Angeles, CA CEO, CFO, 2015 – Present Cyrus is the Creator of the RIOTBOX, A13 KEVLAR HOODIE … shantha venturesWeb30 de mar. de 2024 · 加拉格尔还将现金投入到可疑的投资中，如一个显然是欺诈性的金矿业务和一家名为Hoverink Biotechnologies Inc.的公司，这个公司最初声称是一家休闲气垫船企业，后来则成了科幻风格的防弹衣和神奇的癌症药物的制造商。 shan thatcher personal liabilityWebCyrus Sajna is Interim CEO/CFO at Hoverink Biotechnologies Inc. See Cyrus Sajna's compensation, career history, education, & memberships. shanthari exports pvt ltdWebHOVERINK BIOTECHNOLOGIES, INC. EIN# 46-3590875. BOARD OF DIRECTORS RESOLUTION TO GRANT RESTRICTED STOCK GRANT AWARDS TO EXECUTIVES, BOARD MEMBERS AND CONSULTANTS. Upon a duly made, seconded and unanimously adopted consent, the Board of Directors of HOVERINK BIOTECHNOLOGIES, INC … shanthaveri gopala gowdaWebHoverink Biotechnologies, Inc. 1801 Century Park East., 24th Floor Los Angeles, California 90067 [email protected] ... pon dealer short leaseWeb9 de abr. de 2024 · vous savez lire ? je vous parle des OGM. Et c'est vrai qu'accessoirement, la recette bio de désherbant que l'on voit passer depuis ce matin à base de vinaigre, de sel et de liqu pond dollar exchange rate longer